Table of Contents
2021 - 2027 Ophthalmology Drugs Report on Global and United States Market, Status and Forecast, by Players, Types and Applications
1 Methodology and Data Source
1.1 Methodology/Research Approach
1.1.1 Research Programs/Design
1.1.2 Market Size Estimation
1.1.3 Market Breakdown and Data Triangulation
1.2 Data Source
1.2.1 Secondary Sources
1.2.2 Primary Sources
1.3 Disclaimer
2 Ophthalmology Drugs Market Overview
2.1 Ophthalmology Drugs Product Overview
2.2 Ophthalmology Drugs Market Segment by Type
2.2.1 Lucentis (ranibizumab)
2.2.2 Eylea (aflibercept)
2.2.3 Avastin (bevacizumab)
2.2.4 Restasis (cyclosporine)
2.2.5 Alphagan (brimonidine tartrate)
2.2.6 Lumigan (bimatoprost)
2.2.7 Xalatan (latanoprost
2.3 Global Ophthalmology Drugs Product Segment by Type
2.3.1 Global Ophthalmology Drugs Sales (K Pcs) and Growth (%) by Type (2016, 2020 and 2027)
2.3.2 Global Ophthalmology Drugs Sales (K Pcs) and Market Share (%) by Type ( 2016 - 2021)
2.3.3 Global Ophthalmology Drugs Revenue (Million USD) and Market Share (%) by Type ( 2016 - 2021)
2.3.4 Global Ophthalmology Drugs Price (USD/Pcs) by Type ( 2016 - 2021)
2.4 United States Ophthalmology Drugs Product Segment by Type
2.4.1 United States Ophthalmology Drugs Sales (K Pcs) and Growth by Type (2016, 2020 and 2027)
2.4.2 United States Ophthalmology Drugs Sales (K Pcs) and Market Share by Type ( 2016 - 2021)
2.4.3 United States Ophthalmology Drugs Revenue (Million USD) and Market Share by Type ( 2016 - 2021)
2.4.4 United States Ophthalmology Drugs Price (USD/Pcs) by Type ( 2016 - 2021)
3 Ophthalmology Drugs Application/End Users
3.1 Ophthalmology Drugs Segment by Application/End Users
3.1.1 Chorioretinitis
3.1.2 Choroiditis
3.1.3 Retinitis
3.1.4 Others
3.2 Global Ophthalmology Drugs Product Segment by Application
3.2.1 Global Ophthalmology Drugs Sales (K Pcs) and CGAR (%) by Application (2016, 2020 and 2027)
3.2.2 Global Ophthalmology Drugs Sales (K Pcs) and Market Share (%) by Application ( 2016 - 2021)
3.3 United States Ophthalmology Drugs Product Segment by Application
3.3.1 United States Ophthalmology Drugs Sales (K Pcs) and CGAR (%) by Application (2016, 2020 and 2027)
3.3.2 United States Ophthalmology Drugs Sales (K Pcs) and Market Share (%) by Application ( 2016 - 2021)
4 Ophthalmology Drugs Market Status and Outlook by Regions
4.1 Global Market Status and Outlook by Regions
4.1.1 Global Ophthalmology Drugs Market Size and CAGR by Regions (2016, 2020 and 2027)
4.1.2 North America
4.1.3 Asia - Pacific
4.1.4 Europe
4.1.5 South America
4.1.6 Middle East and Africa
4.1.7 United States
4.2 Global Ophthalmology Drugs Sales and Revenue by Regions
4.2.1 Global Ophthalmology Drugs Sales (K Pcs) and Market Share (%) by Regions ( 2016 - 2021)
4.2.2 Global Ophthalmology Drugs Revenue (Million USD) and Market Share (%) by Regions ( 2016 - 2021)
4.2.3 Global Ophthalmology Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)( 2016 - 2021)
4.2.4 North America Ophthalmology Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)( 2016 - 2021)
4.2.5 Europe Ophthalmology Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)( 2016 - 2021)
4.2.6 Asia - Pacific Ophthalmology Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)( 2016 - 2021)
4.2.7 South America Ophthalmology Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin ( 2016 - 2021)
4.2.8 Middle East and Africa Ophthalmology Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)( 2016 - 2021)
4.2.9 United States Ophthalmology Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin ( 2016 - 2021)
5 Global Ophthalmology Drugs Market Competition by Players/Manufacturers
5.1 Global Ophthalmology Drugs Sales (K Pcs) and Market Share by Players ( 2016 - 2021)
5.2 Global Ophthalmology Drugs Revenue (Million USD) and Share by Players ( 2016 - 2021)
5.3 Global Ophthalmology Drugs Average Price (USD/Pcs) by Players ( 2016 - 2021)
5.4 Global Top Players Ophthalmology Drugs Manufacturing Base Distribution, Sales Area, Product Types
5.5 Ophthalmology Drugs Market Competitive Situation and Trends
5.5.1 Ophthalmology Drugs Market Concentration Rate
5.5.2 Global Ophthalmology Drugs Market Share (%) of Top 3 and Top 5 Players
5.5.3 Mergers & Acquisitions, Expansion
6 United States Ophthalmology Drugs Market Competition by Players/Manufacturers
6.1 United States Ophthalmology Drugs Sales (K Pcs) and Market Share by Players ( 2016 - 2021)
6.2 United States Ophthalmology Drugs Revenue (Million USD) and Share by Players ( 2016 - 2021)
6.3 United States Ophthalmology Drugs Average Price (USD/Pcs) by Players ( 2016 - 2021)
6.4 United States Ophthalmology Drugs Market Share (%) of Top 3 and Top 5 Players
7 Ophthalmology Drugs Players/Manufacturers Profiles and Sales Data
7.1 Novartis
7.1.1 Company Basic Information, Manufacturing Base and Competitors
7.1.2 Ophthalmology Drugs Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Novartis Ophthalmology Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)( 2016 - 2021)
7.1.4 Main Business/Business Overview
7.2 Regeneron
7.2.1 Company Basic Information, Manufacturing Base and Competitors
7.2.2 Ophthalmology Drugs Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Regeneron Ophthalmology Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)( 2016 - 2021)
7.2.4 Main Business/Business Overview
7.3 Roche
7.3.1 Company Basic Information, Manufacturing Base and Competitors
7.3.2 Ophthalmology Drugs Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Roche Ophthalmology Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)( 2016 - 2021)
7.3.4 Main Business/Business Overview
7.4 Bayer
7.4.1 Company Basic Information, Manufacturing Base and Competitors
7.4.2 Ophthalmology Drugs Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 Bayer Ophthalmology Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)( 2016 - 2021)
7.4.4 Main Business/Business Overview
7.5 Allergan
7.5.1 Company Basic Information, Manufacturing Base and Competitors
7.5.2 Ophthalmology Drugs Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Allergan Ophthalmology Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)( 2016 - 2021)
7.5.4 Main Business/Business Overview
7.6 Shire
7.6.1 Company Basic Information, Manufacturing Base and Competitors
7.6.2 Ophthalmology Drugs Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 Shire Ophthalmology Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)( 2016 - 2021)
7.6.4 Main Business/Business Overview
7.7 Mallinckrodt
7.7.1 Company Basic Information, Manufacturing Base and Competitors
7.7.2 Ophthalmology Drugs Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 Mallinckrodt Ophthalmology Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)( 2016 - 2021)
7.7.4 Main Business/Business Overview
8 Ophthalmology Drugs Manufacturing Cost, Industrial Chain and Downstream Buyers
8.1 Ophthalmology Drugs Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Ophthalmology Drugs Industrial Chain Analysis
8.4 Downstream Buyers in United States
9 Marketing Strategy Analysis, Distributors and Market Effect Factors
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Distributors in Untied States
9.3 Market Effect Factors Analysis
9.3.1 Economic/Political Environmental Change
9.3.2 Downstream Demand Change
9.3.3 Technology Progress in Related Industry
9.3.4 Substitutes Threat
10 Global Ophthalmology Drugs Market Forecast
10.1 Global Ophthalmology Drugs Sales, Revenue Forecast ( 2021 - 2027)
10.1.1 Global Ophthalmology Drugs Sales (K Pcs) and Growth Rate (%) Forecast ( 2021 - 2027)
10.1.2 Global Ophthalmology Drugs Revenue (Million USD) and Growth Rate (%) Forecast ( 2021 - 2027)
10.2 United States Ophthalmology Drugs Market Forecast
10.2.1 United States Ophthalmology Drugs Sales (K Pcs) and Growth Rate (%) Forecast ( 2021 - 2027)
10.2.2 United States Ophthalmology Drugs Revenue (Million USD) and Growth Rate (%) Forecast ( 2021 - 2027)
10.3 Global Ophthalmology Drugs Forecast by Regions
10.3.1 North America Ophthalmology Drugs Sales (K Pcs) and Revenue (Million USD) Forecast ( 2021 - 2027)
10.3.2 Europe Ophthalmology Drugs Sales (K Pcs) and Revenue (Million USD) Forecast ( 2021 - 2027)
10.3.3 Asia - Pacific Ophthalmology Drugs Sales (K Pcs) and Revenue (Million USD) Forecast ( 2021 - 2027)
10.3.4 South America Ophthalmology Drugs Sales (K Pcs) and Revenue (Million USD) Forecast ( 2021 - 2027)
10.3.5 Middle East and Africa Ophthalmology Drugs Sales (K Pcs) and Revenue (Million USD) Forecast ( 2021 - 2027)
10.4 Ophthalmology Drugs Forecast by Type
10.4.1 Global Ophthalmology Drugs Sales (K Pcs) and Revenue (Million USD) Forecast by Type ( 2021 - 2027)
10.4.2 United States Ophthalmology Drugs Sales (K Pcs) and Revenue (Million USD) Forecast by Type ( 2021 - 2027)
10.5 Ophthalmology Drugs Forecast by Application
10.5.1 Global Ophthalmology Drugs Sales (K Pcs) Forecast by Application ( 2021 - 2027)
10.5.2 United States Ophthalmology Drugs Sales (K Pcs) Forecast by Application ( 2021 - 2027)
11 Research Findings and Conclusion
List of Tables and Figures
Table Research Programs/Design for This Report
Figure Bottom - up and Top - down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Figure Ophthalmology Drugs Product Picture
Figure Global Ophthalmology Drugs Revenue (Million USD) Status and Outlook ( 2016 - 2027)
Figure United States Ophthalmology Drugs Revenue (Million USD) Status and Outlook ( 2016 - 2027)
Figure Product Picture of Lucentis (ranibizumab)
Table Major Players of Lucentis (ranibizumab)
Figure Global Lucentis (ranibizumab) Sales (K Pcs) and Growth Rate (%)( 2016 - 2021)
Figure Product Picture of Eylea (aflibercept)
Table Major Players of Eylea (aflibercept)
Figure Global Eylea (aflibercept) Sales (K Pcs) and Growth Rate (%)( 2016 - 2021)
Figure Product Picture of Avastin (bevacizumab)
Table Major Players of Avastin (bevacizumab)
Figure Global Avastin (bevacizumab) Sales (K Pcs) and Growth Rate (%)( 2016 - 2021)
Figure Product Picture of Restasis (cyclosporine)
Table Major Players of Restasis (cyclosporine)
Figure Global Restasis (cyclosporine) Sales (K Pcs) and Growth Rate (%)( 2016 - 2021)
Figure Product Picture of Alphagan (brimonidine tartrate)
Table Major Players of Alphagan (brimonidine tartrate)
Figure Global Alphagan (brimonidine tartrate) Sales (K Pcs) and Growth Rate (%)( 2016 - 2021)
Figure Product Picture of Lumigan (bimatoprost)
Table Major Players of Lumigan (bimatoprost)
Figure Global Lumigan (bimatoprost) Sales (K Pcs) and Growth Rate (%)( 2016 - 2021)
Figure Product Picture of Xalatan (latanoprost
Table Major Players of Xalatan (latanoprost
Figure Global Xalatan (latanoprost Sales (K Pcs) and Growth Rate (%)( 2016 - 2021)
Table Global Ophthalmology Drugs Sales (K Pcs) and Growth Rate (%) Comparison by Type (2016, 2020 and 2027)
Table Global Ophthalmology Drugs Sales (K Pcs) by Type ( 2016 - 2021)
Table Global Ophthalmology Drugs Sales Share (%) by Type ( 2016 - 2021)
Figure Global Ophthalmology Drugs Sales Market Share (%) by Type ( 2016 - 2021)
Figure Global Ophthalmology Drugs Sales Market Share (%) by Type in 2020
Table Global Ophthalmology Drugs Revenue (Million USD) by Type ( 2016 - 2021)
Table Global Ophthalmology Drugs Revenue Share (%) by Type ( 2016 - 2021)
Figure Global Ophthalmology Drugs Revenue Share (%) by Type ( 2016 - 2021)
Figure 2020 Global Ophthalmology Drugs Revenue Market Share (%) by Type
Table Global Ophthalmology Drugs Price (USD/Pcs) by Type ( 2016 - 2021)
Table United States Ophthalmology Drugs Sales (K Pcs) and Growth Rate (%) Comparison by Type (2016, 2020 and 2027)
Table United States Ophthalmology Drugs Sales (K Pcs) by Type ( 2016 - 2021)
Table United States Ophthalmology Drugs Sales Share (%) by Type ( 2016 - 2021)
Figure United States Ophthalmology Drugs Sales Market Share (%) by Type ( 2016 - 2021)
Figure United States Ophthalmology Drugs Sales Market Share (%) by Type in 2020
Table United States Ophthalmology Drugs Revenue (Million USD) by Type ( 2016 - 2021)
Table United States Ophthalmology Drugs Revenue Share (%) by Type ( 2016 - 2021)
Figure United States Ophthalmology Drugs Revenue Share (%)by Type ( 2016 - 2021)
Figure 2020 United States Ophthalmology Drugs Revenue Market Share (%) by Type
Table United States Ophthalmology Drugs Price (USD/Pcs) by Type ( 2016 - 2021)
Figure Chorioretinitis Examples
Figure Choroiditis Examples
Figure Retinitis Examples
Figure Others Examples
Table Global Ophthalmology Drugs Sales (K Pcs) Comparison by Application ( 2016 - 2027)
Table Global Ophthalmology Drugs Sales (K Pcs) by Application ( 2016 - 2021)
Table Global Ophthalmology Drugs Sales Share (%) by Application ( 2016 - 2021)
Figure Global Ophthalmology Drugs Sales Market Share (%) by Application ( 2016 - 2021)
Figure Global Ophthalmology Drugs Sales Market Share (%) by Application in 2020
Table United States Ophthalmology Drugs Sales (K Pcs) Comparison by Application ( 2016 - 2027)
Table United States Ophthalmology Drugs Sales (K Pcs) by Application ( 2016 - 2021)
Table United States Ophthalmology Drugs Sales Share (%) by Application ( 2016 - 2021)
Figure United States Ophthalmology Drugs Sales Market Share (%) by Application ( 2016 - 2021)
Figure United States Ophthalmology Drugs Sales Market Share (%) by Application in 2020
Table Global Ophthalmology Drugs Revenue (Million USD) and CAGR Comparison by Regions ( 2016 - 2027)
Figure North America Ophthalmology Drugs Revenue (Million USD) and Growth Rate (%)( 2016 - 2027)
Figure Asia - Pacific Ophthalmology Drugs Revenue (Million USD) and Growth Rate (%)( 2016 - 2027)
Figure Europe Ophthalmology Drugs Revenue (Million USD) and Growth Rate (%)( 2016 - 2027)
Figure South America Ophthalmology Drugs Revenue (Million USD) and Growth Rate (%)( 2016 - 2027)
Figure Middle East and Africa Ophthalmology Drugs Revenue (Million USD) and Growth Rate (%)( 2016 - 2027)
Figure United States Ophthalmology Drugs Revenue (Million USD) and Growth Rate (%)( 2016 - 2027)
Table Global Ophthalmology Drugs Sales (K Pcs) by Regions ( 2016 - 2021)
Table Global Ophthalmology Drugs Sales Market Share (%) by Regions ( 2016 - 2021)
Figure Global Ophthalmology Drugs Sales Market Share (%) by Regions ( 2016 - 2021)
Figure 2020 Global Ophthalmology Drugs Sales Market Share (%) by Regions
Figure 2020 United States Ophthalmology Drugs Sales Market Share (%) in Global Market
Table Global Ophthalmology Drugs Revenue (Million USD) by Regions ( 2016 - 2021)
Table Global Ophthalmology Drugs Revenue Market Share (%) by Regions ( 2016 - 2021)
Figure Global Ophthalmology Drugs Revenue Market Share (%) by Regions ( 2016 - 2021)
Figure 2020 Global Ophthalmology Drugs Revenue Market Share (%) by Regions
Figure 2020 United States Ophthalmology Drugs Revenue Market Share (%) in Global Market
Table Global Ophthalmology Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)( 2016 - 2021)
Table North America Ophthalmology Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)( 2016 - 2021)
Table Europe Ophthalmology Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)( 2016 - 2021)
Table Asia - Pacific Ophthalmology Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)( 2016 - 2021)
Table South America Ophthalmology Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)( 2016 - 2021)
Table Middle East and Africa Ophthalmology Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)( 2016 - 2021)
Table United States Ophthalmology Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)( 2016 - 2021)
Table Global Ophthalmology Drugs Sales (K Pcs) of Key Players ( 2016 - 2021)
Table Global Ophthalmology Drugs Sales Share (%) by Players ( 2016 - 2021)
Figure 2020 Global Ophthalmology Drugs Sales Share (%) by Players
Figure 2021 Global Ophthalmology Drugs Sales Share (%) by Players
Table Global Ophthalmology Drugs Revenue (Million USD) by Players ( 2016 - 2021)
Table Global Ophthalmology Drugs Revenue Share (%) by Players ( 2016 - 2021)
Table 2020 Global Ophthalmology Drugs Revenue Share (%) by Players
Table 2021 Global Ophthalmology Drugs Revenue Share (%) by Players
Table Global Market Ophthalmology Drugs Average Price (USD/Pcs) by Players ( 2016 - 2021)
Table Global Ophthalmology Drugs Top Players Manufacturing Base Distribution and Sales Area
Table Global Ophthalmology Drugs Top Players Product Category
Figure Global Ophthalmology Drugs Market Share (%) of Top 3 Players
Figure Global Ophthalmology Drugs Market Share (%) of Top 5 Players
Table United States Ophthalmology Drugs Sales (K Pcs) by Players ( 2016 - 2021)
Table United States Ophthalmology Drugs Sales Market Share (%) by Players ( 2016 - 2021)
Figure 2020 United States Ophthalmology Drugs Sales Share (%) by Players
Figure 2021 United States Ophthalmology Drugs Sales Share (%) by Players
Table United States Ophthalmology Drugs Revenue (Million USD) by Players ( 2016 - 2021)
Table United States Ophthalmology Drugs Revenue Market Share (%) by Players ( 2016 - 2021)
Table 2020 United States Ophthalmology Drugs Revenue Share (%) by Players
Table 2021 United States Ophthalmology Drugs Revenue Share (%) by Players
Table United States Market Ophthalmology Drugs Average Price (USD/Pcs) by Players ( 2016 - 2021)
Figure United States Ophthalmology Drugs Market Share (%) of Top 3 Players
Figure United States Ophthalmology Drugs Market Share (%) of Top 5 Players
Table Novartis Basic Information List
Table Novartis Ophthalmology Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)( 2016 - 2021)
Figure Novartis Ophthalmology Drugs Sales
